Clinical trial
Evaluation of Hemostasis in Bleeding and Thrombotic Disorders
NCT00178594 · The University of Texas Health Science Center, Houston, Other · Recruiting
Key facts
| NCT number | NCT00178594 |
|---|---|
| Title | Evaluation of Hemostasis in Bleeding and Thrombotic Disorders |
| Official title | Evaluation of Hemostasis in Bleeding and Thrombotic Disorders Using the Roteg Analyzer and the Thrombin Generation Assay |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Blood Coagulation Disorders, Inherited, Thrombotic Disorder |
| Enrollment | 1,000 |
| Start date | Oct 1, 2002 |
| Primary completion | Jan 1, 2028 |
| Completion | Jan 1, 2028 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 9, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: